drugset / Trial / NCT02334878
Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the effectiveness of mesenchymal stem cells in treatment of stress urinary incontinence due to intrinsic sphincter deficiency; in which the problem is weakness or damage of the sphincter muscle responsible for continence. Mesenchymal stem cells are undifferentiated cells which can undergo self-renewal \& differentiation into other cell types like muscle cells; thus can be used to regenerate the damaged sphincter muscles. In this study mesenchymal stem cells will be obtained from bone marrow from the patient, processed, \& then re-injected periurethrally. Effectiveness will be compared to that of the surgical treatment (tension-free vaginal tape).
Timeline
- Start
- 2015-10-01
- Primary completion
- 2016-10-30
- Completion
- 2016-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 2e+07 cells | Other |
| Subject | mesenchymal stem cells | Cell therapy | 3e+07 cells | Other |